Edwards Lifesciences EVOQUE

Edwards’ EVOQUE valve system granted CE Mark

CE-marked EVOQUE valve system, a breakthrough for tricuspid valve replacement. Edwards Lifesciences Corporation has officially announced that their EVOQUE tricuspid valve replacement system has received CE Mark approval for transcatheter treatment of patients with tricuspid regurgitation (TR). This achievement marks a significant milestone, as the EVOQUE system becomes the world’s Leggi tutto…